市場調查報告書
商品編碼
1532133
印度維生素D補充劑市場評估:依類似物、依成分、依銷售方式、依劑型、依治療用途、依最終用戶、依地區、機會、預測(2018年度-2032年度)India Vitamin D Supplements Market Assessment, By Analog, By Source, By Sales Method, By Dosage Form, By Therapeutic Applications By End-user, By Region, Opportunities and Forecast, FY2018-FY2032F |
印度維生素D補充劑市場規模預計將從2025年度的1.0104億美元增至2032年度的1.8841億美元,預計在2025年度至2032年度的預測期內年複合成長率為8.10%。維生素D缺乏症盛行率的上升、人們對補充劑及其在維持健康方面的作用的認識不斷提高、主要市場參與者推出新產品以及提高公眾意識的努力推動了市場的成長。
此外,印度保健補充劑的普及也支持了市場成長。2022年9月,Apollo Hospitals Group旗下的Apollo Pharmacy宣佈在印度開設第5,000家門市。這種擴張預計將增加各種含有維生素D的保健品的銷售機會,為市場提供有利的成長機會。
主要市場參與者加大努力改善警察的健康和福利也對市場擴張產生正面影響。2021年 7月,Fermenta Biotech Limited 向馬哈拉施特拉邦警方捐贈了維生素D3膠囊,作為Help Protect Our Protectors計畫的一部分。總共捐贈了 160 萬粒膠囊來幫助軍人增強免疫系統,因為維生素D在降低呼吸道感染風險和支持免疫力方面發揮著重要作用。
維生素D缺乏症的增加刺激了市場需求
印度維生素D缺乏症的盛行率日益增加,是推動印度維生素D補充劑市場需求的主要因素之一。 Nature發表的一篇論文估計,印度約有 4.9億人缺乏維生素D,其中 31%是青少年和兒童。這種增加可能是由於陽光照射不足、阻礙紫外線穿透的污染、不良飲食和咖啡因攝取過多所造成的。由於人們越來越認識到與維生素D缺乏相關的各種不利影響以及膳食補充劑的日益普及,預計未來幾年市場需求將會增加。人們對自己的健康變得更加積極主動,並開始尋求各種補充劑來支持他們的健康並解決各種營養缺乏問題。此外,政府加強應對維生素D缺乏症以及實施基於人口的干預和教育策略預計將支持市場擴張。
新產品發布促進市場成長
各家公司加強投資力度,在印度推出新型保健補充劑,預計將擴大印度維生素D補充劑的市場規模。2023年 7月,Oriflame India宣佈在印度推出 Wellosophy 系列的兩種新保健補充劑:鎂強化鈣、維生素D和鐵複合物。這些補充劑可幫助保持積極、健康的生活方式並支持忙碌的日常生活,由瑞典營養委員會經過廣泛研究和開發而開發。此類產品的推出,以及人們對膳食補充劑各種益處的認識不斷提高,推動市場需求,並預計將對未來幾年的市場擴張產生積極影響。此外,隨著人們健康意識的提高以及對維生素D補充劑各種益處的認識的提高,預計將在預測期內顯著增加市場需求。
維生素D3預計將佔據主要市場佔有率
這個細分市場的擴張是由於人們越來越認識到維生素D3的各種健康益處,包括改善鈣吸收、改善骨骼健康、情緒調節和改善免疫功能。此外,生活方式的改變和室內方向的增加也增加了對維生素D3的需求。因此,每天補充維生素D3被全國各地的人們提倡。此外,維生素D3補充劑的供應量不斷增加、不同口味的多種選擇以及服用維生素D3補充劑的便利性推動這一細分市場的成長。 Carbamide Forte 提供 維生素D3 60000 IU 咀嚼片。該藥每週服用一次,有橘子味。
本報告研究和分析了印度維生素D補充劑市場,提供市場規模和預測、市場動態、主要參與者的現狀和前景等。
India Vitamin D supplements market is projected to witness a CAGR of 8.10% during the forecast period FY2025-FY2032, growing from USD 101.04 million in FY2025 to USD 188.41 million in FY2032. The growth of the market is supported by the rising prevalence of vitamin D deficiency, increasing awareness about supplements and their role in maintaining health, novel launches by key market players, and increasing government initiatives to enhance public awareness.
Additionally, the growth of the market is supported by the increasing accessibility to health supplements in India. In September 2022, Apollo Pharmacy, which is a part of the Apollo Hospitals Group, announced the opening of their 5000th outlet in India. Such expansions are expected to augment the accessibility to different health supplements including vitamin D and provide lucrative growth opportunities to the market.
Also, the increasing efforts of major market players to enhance the health and the well-being of police personnel is positively influencing the market's expansion. In July 2021, Fermenta Biotech Limited donated vitamin D3 capsules as part of the Help Protect Our Protectors initiative for Maharashtra Police. In total 1.6 million capsules were donated to allow the personnel to strengthen their immunity as vitamin D reduces the risk of respiratory infections and plays a crucial role in providing immune support.
Increasing Vitamin D Deficiency Boosts Market Demand
The rising incidences of Vitamin D deficiency in India is one of the major factors bolstering the India Vitamin D supplements market demand. According to the estimates of an article published in Nature, approximately 490 million individuals in India have vitamin D deficiency, of which 31% are adolescents and children. The increase can be attributed to inadequate exposure to sunlight, pollution hampering penetration of ultraviolet rays, dietary insufficiencies, and high intake of caffeine. The market demand is expected to increase in the coming years due to the growing awareness about the various negative effects associated with deficiency of vitamin D and the growing popularity of health supplements. The population is becoming more proactive about their health and is leaning on various supplements for supporting their well-being and addressing various nutritional deficiencies. Additionally, increasing government initiatives and implementation of population-based interventional and educational strategies for combating vitamin D deficiencies are expected to support the market's expansion.
Novel Launches Support Market Growth
The rising investments by various companies towards the introduction of new health supplements in the country is expected to increase the India Vitamin D supplements market size. In July 2023, Oriflame India announced the launch of two new health supplements under their Wellosophy range, calcium fortified with magnesium, vitamin D, and iron complex in India. These supplements aid in maintaining active and healthy lifestyles and support busy routines developed after extensive research and development by the company's nutrition council in Sweden. Such launches, coupled with the growing awareness about various advantages associated with health supplements, are propelling the market demand and are expected to positively influence the expansion of the market in the coming years. Additionally, due to the increasing health consciousness among the population and rising awareness about different benefits associated with vitamin D supplements is expected to increase market demand significantly over the forecast period.
Vitamin D3 Expected to Account Significant Market Share
The expansion of the segment is supported by the growing awareness about various health benefits offered by vitamin D3 including improved calcium absorption, which aids in improving bone health, mood regulation, and improved immune functions. Additionally, the requirement for vitamin D3 is rising due to changes in lifestyle and increased preference for indoors. Thus, propelling the adoption of Vitamin D3 supplements in daily regimens by various individuals across the country. Moreover, the increasing accessibility to these supplements and availability of a wide range of options in varying flavors coupled with easy to consume nature of these supplements is bolstering the growth of the segment. Carbamide Forte offers Vitamin D3 60000 IU chewable tables that are required to be consumed only once a week and are available in orange flavor.
Prescription Anticipated to Hold Significant Market Share
The requirement for vitamin D prescription is increasing in India due to the rising cases of vitamin D deficiency, increasing emphasis on maintaining bone health, expansion of the geriatric population, and rapid population growth. The increasing prevalence of vitamin D deficiency in children is expected to boost the expansion of the segment. According to a multicenter study published in Nature, the prevalence of vitamin D deficiency in children and adolescents ranged from 30%-98% in West India. Additionally, vitamin D deficiency is often associated with a higher risk of heart failure and vitamin D, assuming a protective role against cardiovascular diseases, thus propelling the requirement for vitamin D prescriptions. Various findings have shown that vitamin D could reduce the occurrence of cardiovascular events such as coronary revascularization and myocardial infraction.
Future Market Scenario (FY2025 - FY2032F)
The demand of the India Vitamin D supplements market is expected to increase significantly in the coming years due to the growing awareness about the various advantages associated with the supplements, rising prevalence of Vitamin D deficiency, and increasing expenditure on health supplements. The rising awareness about the role of Vitamin D in regulating the amount of phosphate and calcium in blood is expected to further bolster their consumption as these nutrients aid in maintaining the muscle, teeth, and bone health and lack of vitamin D can cause conditions such osteomalacia and bone deformities.
Key Players Landscape and Outlook
The growth of India Vitamin D supplements market is supported by the rising investments by the key market players towards the introduction of novel solutions in the country for effectively treating Vitamin D deficiency. In February 2024, Cadila Pharmaceuticals Limited launched the first aqueous Vitamin D injection which is expected to revolutionize the Vitamin D treatment. This development is expected to improve patient care by increasing the efficacy of the treatment and ensuring a painless and simple administration procedure. Such innovations are anticipated to enhance treatment outcomes and allow healthcare professionals to meet the unmet medical requirements of the patients.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.